BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3876908)

  • 1. Immunotopography of splenic lymphoma of small cleaved B-cell type.
    Grogan TM; Rangel CS; Wirt DP; Richter LC; Bever FN; Jolley CS; Villar HV; Jones SE
    Diagn Immunol; 1985; 3(3):126-32. PubMed ID: 3876908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two major B cell forms of nodular mixed lymphoma.
    Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
    Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mantle-zone lymphoma. A pattern produced by lymphomas of more than one cell type.
    Harris NL; Bhan AK
    Am J Surg Pathol; 1985 Dec; 9(12):872-82. PubMed ID: 2933967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further delineation of the immunoarchitecture of the human spleen.
    Grogan TM; Rangel CS; Richter LC; Wirt DP; Villar HV
    Lymphology; 1984 Jun; 17(2):61-8. PubMed ID: 6206363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three cases of primary splenic lymphoma. Case report and review of the Japanese literature.
    Hara K; Ito M; Shimizu K; Matsumoto T; Suchi T; Iijima S
    Acta Pathol Jpn; 1985 Mar; 35(2):419-35. PubMed ID: 3895823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic complexity of lymphoblastic lymphoma.
    Grogan T; Spier C; Wirt DP; Hicks MJ; Paquin M; Hutter J; Miller T; Rangel C; Richter L; Jones S
    Diagn Immunol; 1986; 4(2):81-8. PubMed ID: 3086016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
    Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
    Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
    Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
    J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of cell surface molecules on a differentiating, Ly-1+ B cell lymphoma.
    Ovnic M; Corley RB
    J Immunol; 1987 May; 138(9):3075-82. PubMed ID: 3494780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
    Lauder I; Bird CC; Child JA; Grigor I
    J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunoarchitecture of cutaneous pseudolymphoma.
    Wirt DP; Grogan TM; Jolley CS; Rangel CS; Payne CM; Hansen RC; Lynch PJ; Schuchardt M
    Hum Pathol; 1985 May; 16(5):492-510. PubMed ID: 3157635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma.
    Franco V; Florena AM; Ascani S; Paulli M; Salvato M; Pileri SA
    Histopathology; 2004 Apr; 44(4):381-6. PubMed ID: 15049905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
    Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
    J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
    Mollejo M; Menárguez J; Lloret E; Sánchez A; Campo E; Algara P; Cristóbal E; Sánchez E; Piris MA
    Am J Surg Pathol; 1995 Oct; 19(10):1146-57. PubMed ID: 7573673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.